Low molecular weight fucoidan inhibits hepatocarcinogenesis and nonalcoholic fatty liver disease in zebrafish via ASGR/STAT3/HNF4A signaling. The gene discussed is HNF4A; the disease is metabolic dysfunction-associated steatotic liver disease.